Biotech companies especially those tackling Covid-19 are seeing incredible bumps on the boards with companies like Canadian Sona Nanotech (SONA.C), based out of Halifax, Nova
Biotech companies especially those tackling Covid-19 are seeing incredible bumps on the boards with companies like Canadian Sona Nanotech (SONA.C), based out of Halifax, Nova
“Spectrum Therapeutics’ medical patients can have confidence that their legal cannabis purchases will arrive at their door in a safe and timely fashion,” stated Rosy Mondin, CEO of World-Class
H1 ETF inflows are higher than the record-setting central bank net purchases seen in 2018 and 2019, and “could absorb a comparable amount of about 45% of global gold production.”
Gotcha has seen drastic increases in profitability across its various end markets, driven primarily by increases of 53% and 208% in riders per month and minutes ridden per month, respectively.
“Visual confirmation of test results (probe activation) was observed in five to seven minutes,” states Xphyto.
This $15 million company owns 11 projects on two continents.
Gross revenue was $1.4-million in the second quarter of 2020, compared with nil in the three-month period ended April 30, 2019.
Mining jurisdiction, geology, metallurgy – all good.
“In a sector rife with terrible CEOs that have wasted company treasury and goodwill…none come close to Bierman in terms of self enrichment, entitlement, and outward facing douchery,” wrote Chris Parry on January 31, 2020.
Heimark has a track record of rigorous market research prior to launching products. This research-based approach has reaped dividends in market penetration and revenue growth.
Bayer AG (BAYN.FRA) rode a rickety roller coaster when the life science company announced it had acquired global ag biotech giant, Monsanto in June 2018,
Today, The International Monetary Fund (IMF) released a statement predicting that the global economy will take a $12 trillion hit from the Covid-19 pandemic. $12
For a company with a modest market cap ($9.5 million) Nexus has a good track record of advancing multiple projects simultaneously on two continents (North America and Africa).
CBD-focused CSE companies Sweet Earth (SE.C) and Mota Ventures (MOTA.C) have announced their intent to join forces on the development and distribution of CBD dog
The company is planning a large-scale secondary graphite transformation facility, catering to the needs of the booming lithium-ion battery industry. The Matawinie graphite project will be the first of its kind to operate as an all-electric, low-carbon mine.
In streaming content news, the recent Microsoft experiment of trying to compete with Amazon-owned Twitch with their own Mixer platform, has come to a sorry
This week’s digest of mushroom moves is a mixed bag of trash and glory, with the shrooms sector increasingly looking like the early days of the cannabis rush.
The total Global Defense Budget is estimated at around USD $1.8 Trillion in 2020 and the market is expected to grow to around USD $2.3 Trillion by 2028.
Loblaws’ (L.T) big ass 1300-store pharmacy chain, Shoppers Drug Mart, announced this morning they’re now offering same day delivery of medical cannabis products in the
Our early coverage of Xphyto reveals the following company trait: Xphyto says, “We’re going to do this” – and then they do it – quickly.
The Greater Fool Theory is the single greatest driving force of the markets right now. Balance sheets can eat a dick. Growth potential is irrelevant.
When we first heard of Vodis Pharma (VP.C) it was a tiny group that couldn’t get its unlicensed Delta BC-based cannabis facility looked at by
If you stop and think about it, the fact that Vext Science (VEXT.C) only lost USD$1 million in Q1 of 2020 is fantastic. Today’s news,
When a company shows up out of nowhere and announces they’re buying a newspaper, but that nothing will change if not for the better, that they have money and resources to compliment what’s already there, and that journalism will always be at the core of what they do, don’t buy it. It’s always a lie. In March, Media Central (FLYY.C) CEO Brian Kalish got in front of a camera to talk about how, ‘hey guys, we know the Georgia Straight has been around for 53 years, but we’re bringing it back to its heart.’
Predictmedix and MobileWellbeing are attacking the Telehealth problem from different angles.
the answer to a metals-analyst “when-question” should never include allusions to wine, chickens or pornography (a date would be more instructive).
Vektor is now proceeding with process implementation for the manufacture of Rotigotine patches for human clinical studies.
Ever get the feeling, looking at your watchlist, that you’re seeing the same thing over and over? That maybe there’s interesting stuff out there you just haven’t heard about yet? I put a simple question to Twitter today: “Give me a ticker symbol you think I should be writing about (limit one per person), three reasons you think it’s great, and one thing you’ll openly admit they need to do better.” I got 35. Gulp.
I love it when a plan comes together. Predictmedix (PMED.C) continued to launch itself upward this week, jumping from $0.72 to $0.98 in just days,
The results have confirmed the presence of gold mineralization to a depth of 83 metres below surface of the historic Central Canada Gold Mine
This company is completing a $2 million go-public financing. We believe KWESST is committed to building a wide shareholder base
“This will be the third year we have had the opportunity to partner with a local organization during pride month,” stated Mr. Heimark. “Last year we sold over 60,000 units and are looking forward to giving that record a run for its money this year.”
Far be it for me to stand up for Canopy Growth Corp (WEED.T), a company that has only succeeded in one thing in its entire existence; convincing folks to buy its stock despite never having done anything else right. In recent quarters, and through three CEOs, Canopy has been pretty darn forthright that it was going to lose money for a while because it was broken.
Stuck at home, but armed with online trading apps, individual investors helped drive the historic comeback for stocks
Because this story is about The Green Organic Dutchman (TGOD.T) and cannabis investors bear grudges, the vast majority of people reading it will already be saying the words, “Fuck Parry, you’ll pump anything for money.”
So let’s get some things out of the way before we start. 1) TGOD isn’t paying for this story, and haven’t been a client for well over a year. 2) TGOD might not be a fan of this story
Growing cannabis revenues, shrinking losses, a healthy balance sheet – and now a pathway to selling branded extraction products into the Canadian market.
To be blunt, Hexo is selling $15 pizzas with food-costs of $40. It’s not a great business model.
When weed legalized in Canada, I wasn’t a consumer participant. Smoking up has never been my jam. I know some like the ritual of it
This proposed investment will fund the advanced development and deployment of the Patscan VRS health and safety detection modules for thermal elevated body temperature, facial mask screening, social distancing and contact tracing as part of the Company’s suite of video object recognition solutions.
“Predictmedix’ best-in-class screening technology pairs perfectly with our ability to custom-fabricate quickly and efficiently,” states Jonathan Auger, CEO of Juiceworks Exhibits
When the history books are written on this passage of our lives, under pandemic lockdown and with once-in-three-generations levels of unemployment, they’ll note that in
“This is a challenging time around the world and here at home in Canada,” confirmed CEO Rosy Mondin, “The operational adjustments announced today are an important step in streamlining our direction and preserving resources to be utilized in more focused priorities.
Micro-mobility ride-sharing, which is the terminology that’s been coined for e-scooters, bike-shares, mopeds and the like, is clearly an idea that has a future. Small enough to park anywhere (we’ll get to the dark side of that in a second), cheap enough to mass produce, able to be electrified and charged easily, and tied to a payment app that tracks a load of data, this business concept has everything going for it – and is being fucked up by just about everyone involved.
Revive Therapeutics is exploring the use of the drug Bucillamine as a potential novel treatment for infectious diseases including influenza and the coronavirus disease (Covid-19)
Two weeks ago, Predictmedix filed a Patent Application in the U.S. for its AI-driven rapid screening system for infectious diseases.
If Tilray (TLRY.Q) will leave any sort of legacy on the Canadian cannabis landscape, it will be that, for a short time and by virtue of a well-timed and paper-lined public listing, the CEO was the highest paid CEO in North America. For a hot minute, Americans bought in by the truckload and drove the shareprice up like DryShips (DRYS), making the boss a very paper rich man. Everything else the company has managed to achieve has been downhill from there.
We get a lot of clients wanting to be written about on Mondays because that’s when everyone drops their good news. I usually try to
Growing old is a messy business.
Institutional care for seniors will never provide perfect solutions.
The challenge is not to make a perfect system, but to mitigate the health risks of long term care, intelligently and ethically.
How can cruise industry recover from this shit-storm of bad voodoo?
The same way it always recovers from shit-storms of bad voodoo.
I break laws sometimes. I speed on the highway. I possess more than the 30 gram legal limit of weed products. I sneak food into
“Nothing can basically stop America,” stated Buffett at Saturday’s virtual shareholder meeting. “The American miracle, the American magic has always prevailed and it will do so again.”
Buffett’s opinion (about the resiliency of the U.S. economy) has been right for six decades. Why wouldn’t it continue to be right?
For a company that once upon a time figured a great business model in the cannabis sector would be to tattle on other license holders
New licenses, deals, products – that’s all good – but it’s not the nitty gritty stuff investors are looking for now.
By “nitty-gritty” we mean – numbers.
Four weeks ago, Heritage released its Q1, 2020 financials.
Supreme Cannabis (FIRE.T) got a new President and CEO today in Beena Goldenberg, former chief executive officer of Hain-Celestial Canada, and a bona fide pro in the natural and plant-based consumer packaged goods business. This would appear to be a good hire for a company that already has a great reputation for quality products in an industry where the only way to differentiate yourself is being absurdly cheap or absurdly good. She’s picked a fine time to jump in; the company has already done some hard work in turning its fortunes around, and (to me) looks like its found a nice bottom to launch off.
“Unfortunately, the epidemic of gun violence continues to plague us,” stated Chicago Mayor Lori Lightfoot, who has begged hand-gun owners to disarm so local hospitals can focus on coronavirus patients – not gunshot wound victims.
At Equity.Guru, we’ve been tight with Nexus Gold (NXS.V) boss Alex Klenman for years. he’s been through it with Nexus, from former CEOs selling off his stock in secret, filing their insde trading docs a year late, to stock promoters demanding money and then, upon being refused, crashing the stock, to dark pool shenanigans and more. We’ve laid out a lot of those issues in the past as an explanation how a gold explorer that seems to have some interesting land packages, and does regular work, can find itself so damnedly underwater for so long. Company puts out news, stock starts to lift, massive selling bangs it down. Company puts out news, massive sell orders show up that spook the market, stock drops, sell orders go away.
“Let them say what they want, we know what we’re doing, and we’re doing the work,” Michael Frank told me a month ago, as he
“We have achieved a partnership agreement with a farm operation that is constructed,” stated Isracann CEO, Darryl Jones, “it has already closed a major offtake agreement for the next three years. This accelerates our timeline to production and revenue.”
XPHY owns a German narcotic manufacturer called Vektor Pharma, another subsidiary called Bunker that has all the licenses to study cannabis as a medicine, and it has formed multiple partnerships with universities and research centers.
“Medical marijuana dispensary owners who opted to expand into the adult-use market largely would do so in their existing physical locations,” stated The Phoenix New Times, “adding new staff and providing separate sales counters for medical and retail customers.”
Karim Rayani is a deal guy from way back, a non-stop money raiser, deal maker, handshaker and groover/shaker. If you needed a guy to invest in a biotech deal, Karim would go find him. If you needed some dough to kickstart a palladium mine, Karim will have a guy who knows a guy. And if you needed someone to write about your company, he’d be on the phone bothering me several times a day, squeezing me on my rate, selling me a tale that these guys. “My man, these guys, you have to meet them, they have something special. Sometimes it would even be special.
There’s no doubt a lot of people invest in a sector by just plopping their dough behind whichever company is the biggest, or the one
On April 14, 2020 Last Mile Holdings (MILE.V) announced a new delivery service for restaurants, grocery stores, and other local businesses. It’s a smart adaptive
The Wayland Group (WAYL.C) announced Thursday Austria-based Ring Holding International AG will purchase their Maricann assets, which essentially make up their entire business, for the bargain price of $12.3 million as part of ongoing bankruptcy proceedings. The purchaser of the Maricann assets is a family office with a core focus on the manufacturing of lever arches used in ring binders. Yes, ring binders.
“The simple fact of the matter is ACB is getting around a THIRD of their product returned in real dollar terms,” wrote Equity Guru’s Chris Parry two months ago, “That means they either REALLY suck at growing weed, or they really sucked at figuring out what the market was going to look like when planning their business.”
“Borrowing money and expanding hard in competition with MedMen (MMEN.C) is a two-edged sword,” explained Equity Guru’s Chris Parry, “In a strong market, you’re building far more value than you’re borrowing but, in a down market, you’re under extra pressure to keep things together when debts come due.”
Oddball pharmaceutical player Revive Therapeutics (RVV.C) found itself on the back end of a warning by the BCSC this week, that certain German players in the smallcap promotion space had over-hyped the mushroom/cannabis/biotech deal and promised big wins inappropriately for anyone who invested. As a marketing partner of Revive, I got a few panicky texts from certain folks wondering if that meant trouble for us – or them. It’s not a problem for us; our coverage has been appropriately even-handed.
When the cannabis edibles space first became a potentially legal thing in Canada, my first thought was about how my life would change for the
OIL’s CEO, Paul Pedersen, believes the key to a strong sustainable cannabis extraction business is innovative technology protected by international patents.
Long time readers know, a year or two back, we wrote a lot about a US multi-state operator (MSO) in the cannabis dispensary space, iAnthus (IAN.C). We liked the company as it accelerated its dispensary acquisition program but stopped coverage in early 2019, with the shareprice in the $5 range, as it began to overpay for assets in a land grab with competitors we believed would ultimately have few winners. Today, iAnthus has put out some uncomfortable news announcing that, because it is involved in a lawsuit with creditors, it has chosen to default on debenture interest payments.
In the last 60 days, the DJIA fell 24%, gold is dithering at USD $1,670, GDX.NYSE sold off 11% and the GDXJ.NYSE fell 26%.
I have a list of companies that want me to write about them that, for the last few years, has never got to an end.
It’s never been clearer that many Canadian cannabis companies were built, from the outset, poorly. As the economy creaks and groans and every sector takes
March, 2020 PED revenues increased 265% from those in January, 2020 – as the company’s operations ramp up to satisfy growing demand.
Last week, Nevada Governor Steve Sisolak allowed the shops to continue at-home deliveries because marijuana is considered an “essential business”, reported The Reno Gazette, “Much like the grocery stores trying to fill orders for rice and potatoes, cannabis retailers cannot fill marijuana delivery orders fast enough.”
“Last Mile’s OJO chain is growing fast, and in a controlled, responsible, and municipally welcomed fashion,” stated Equity Guru’s Chris Parry on March 13, 2020, “It’s a half billion dollar company in the making, in a $9 million market cap package”.
“More than 4 million adults experience chronic daily migraine – with at least 15 migraine days per month,” states The Migraine Research Foundation, “It affects 39 million people in the U.S. and 1 billion worldwide.”
Trust me, there’s nothing I’d like more, as the publisher of a financial markets-focused media outlet, than to tell you all it’s time to buy
We are currently primarily focused on wholesale, selling bulk products. Quickly, we will be pivoting to the $16 billion dollar industry which breaks out between nutraceuticals, beauty aids, food and beverages.
While the Noveau-riche cannabis bosses partied with company credit cards, Plus Products put its head down, did the researching, the strategizing, eventually building products that sold like hotcakes.
When new sectors emerge, as cannabis did in 2013 and psychedelics are doing right now, microcap companies that have struggled in other sectors will often pivot into new business. Miners become weed companies, then biotech companies, then shroom companies, as boards and management pursue new opportunities that might one day prove better than the last.
GTEC Holdings (GTEC.C) is a company we’ve written about a lot, a BC-based cannabis grower that laid out a business model of multiple small licensed grow facilities, hitting the premium artisan weed market. Their products are great, their costs are low, and they’ve never yet benefited from the irrational weed booms of the ’15, ’16, and ’17 years because they were late to get those licenses.
This means, they’ve experienced all the weed industry dives, but none of the runs. Their stock price: $0.09, good for a market cap of just $11 million.
“I’m practicing as much social distancing as I possibly can” stated Dr. Anthony Fauci, White House Director of Disease, “I’m working on getting the boss [Trump] to do this. I may not be successful, but we’re working on it.”
Last week, NMC admitted that it identified an additional $2.7 billion in debt, rounding the total debt to around $5 billion. NMC staff were not paid last month.
When the savings and loan crisis in the US hit in 1989, a lot of slow-moving investors lost their dough thinking the worst couldn’t possible
“It’s the financials that are really getting killed,” stated Schiff, “They have made all the loans that are not going to get repaid, so this is just like 2008, only it’s not just the banks that are going to need a bailout, it’s the hotels, it’s the airlines, it’s companies like Boeing, it’s the cruise lines.”
“The National Marriage Project dubbed the drop in divorce ‘a silver lining’ to the Great Recession,” stated The L.A. Times, “arguing that tough times were pulling many husbands and wives closer together.”
No company in the Canadian cannabis space polarizes people like Green Organic Dutchman (TGOD.T), which roared to the public markets on perhaps the biggest promote yet seen, raised nine-digit totals along the way, swept in more first time private placement participants than any company before them, and then did… well… nothing, for a long time. With top brass having been walked recently and plans to super-size the company grow facilities shelved in the wake of underwhelming need for more weed, TGOD has made no secret it is at a moment of recalibration, but investors will have expected to see more than this.
When a sector gets hot, small cap stocks can often get a bump by sidling up to the hot sector with a new product/idea/opportunity. When the dust clears, the intrinsic value of the new offering is typically deemed to be low. We saw it in 3D-printing, with Dung Beetle Treats. We saw it in weed with a $1 billion website that forgot to sell cannabis. We saw it in blockchain with a Cryptocoin for porno transactions.
Okay, so the world is burning, the Russians and Saudis are pouring low-cost fuel over it, the Americans are shocked that a reality TV show
Dixie Brands (DIXI.U.) signed an exclusive binding term sheet to merge with cannabis branding house, BR Brands, today. The deal will constitute a reverse takeover
MILE now has the broadest product profile in the micro-mobility space, featuring a pedal bike, e-bike, standup scooter, seated scooter and trike,” stated Max Smith, CEO of MILE. “Offering multi-modal solutions is key to expanding our network.”
On March 9, 2020 Patriot One (PAT.T) announced that it has been awarded a contract for the PATSCAN Multi-Sensor Covert Threat Detection Platform by Innovation
Hive Blockchain (HIVE.V) announced the expansion of its GPU base digital currency mining facility in Sweden today. It’s only 65 days to the Bitcoin halving,
Digital Realty (DLR.NYSE) has opened its latest data-centre facility in Dublin, Ireland. Digital Realty’s business model includes data centres, colocation, and interconnection solutions. They sell these
When cannabis was legalized in 2017, it was thought to be more akin to a land of milk and honey for investors. Everyone was going